Biotech & pharma
Researchers build cardiac tissue using gold nanowires for heart attack patients
By Emily Finn, MIT News Office | 26 Sep 2011
New cardiac patch uses gold nanowires to enhance electrical signaling between cells, a promising step toward better treatment for heart-attack patients.
Hope for powerful new C Diff. treatment
20 Sep 2011
Scientists 'disarm' HIV in step towards vaccine
20 Sep 2011
Fail-safe system may lead to cures for inherited disorders
By By Scott LaFee | 17 Sep 2011
Scientists find a previously unknown fail-safe pathway potentially protects the brain and other organs from genetic and environmental threats
A call to arms for synthetic biology
15 Sep 2011
Scientists synthesise one arm of yeast chromosome, develop new method for "scrambling" DNA
New hope for hepatitis C vaccine
15 Sep 2011
Invention unravels mystery of protein folding
15 Sep 2011
Cancer-killing cells caught on film in greater 3D detail than before
14 Sep 2011
Scientists reveal how a type of white blood cells, called Natural Killer cells, protect the body from tumours and virus-infected cells
Men also wired for childcare
14 Sep 2011
New hope for HIV vaccine
10 Sep 2011
Bacteria shed light on new drug targets for inherited cancers
09 Sep 2011
Scientists have succeeded in purifying a protein found in bacteria that could reveal new drug targets for inherited breast and ovarian cancers as well as other cancers linked to DNA repair faults
Innovative nanoparticle purification system using magnetic fields may aid medication, diagnostics
08 Sep 2011
New drugs for dangerous yeast infections
06 Sep 2011
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
